Explore more publications!

Africa News Observer: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa News Observer.

Press releases published on November 7, 2025

LIFE Delivers Lifesaving Medical Aid to Over 15,000 People in Sub-Saharan Africa
Policy Management Software Market Reach USD 3.06 Billion Driving at 15.7% CAGR by 2027 Globally
Knowledge Networks Joins ECOSOCC Pre-G20 Dialogue to Advance Inclusive AI Governance ahead of Johannesburg
The Signature Foundation and Kids Lacrosse Africa Launch Fundraiser to Empower Youth Through Sport and Education
Summit Royalties Announces Appointment of Jerrold Annett as Chairman; Trading to Commence on Venture Exchange; Other Corporate Updates
Refined Energy Corp. Closes Private Placement for Gross Proceeds of C$2M
GFG Closes Final Tranche of Financing
Maxus Mining Announces Closing of Flow Through Private Placement
BOKE Foundation’s SDG Hero Program Showcased at the UNU Macau AI Conference 2025
Replimune Presents Late-Breaking Abstract and Additional Posters on RP1 at 40th Annual Meeting of the Society for the Immunotherapy of Cancer (SITC 2025)
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Cellectis Reports Third Quarter 2025 Financial Results and Provides Business Update
Taseko to Release Third Quarter 2025 Results
Lithium Argentina to Release PPG Scoping Study Results with Third Quarter 2025 Earnings
InflaRx to Announce Topline Data from Phase 2a Clinical Trial of INF904 in Hidradenitis Suppurativa and Chronic Spontaneous Urticaria
Real-World Evidence Studies of XPHOZAH® (tenapanor) Demonstrate Patient Satisfaction and Reduction in Serum Phosphate with XPHOZAH in Data Presented at ASN Kidney Week
Vapers Misled? Scientists Say Puff Counts Don’t Mean What You Think
ALEMEDA DROPS NEW EP  BUT WHAT THE HELL DO I KNOW PERFORMING AT TYLER, THE CREATOR’S CAMP FLOG GNAW ON NOVEMBER 15
XS.com conquista duas vitórias no Dubai Affiliate Summit: Melhor Programa de Afiliados e Melhor Suporte
ADARx Pharmaceuticals Announces Positive Interim Phase 1 Clinical Data for its Novel siRNA Targeting Complement Factor B (CFB)

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions